pentobarbital will decrease the level or influence of roflumilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not proposed; powerful cytochrome P450 enzyme inducers lessen systemic publicity to roflumilast and should lessen the therapeutic successpentobarbital will increase toxicity of ifosfamide by… Read More